Stocks We Like

QBE Insurance’s (ASX:QBE) first-half 2024 (1H24) results offer a nuanced picture.  Depending on your interpretation of the performance of the American business, QBE Insurance is either off to a challenging start to the year, or long-term prospects remain optimistic, largely driven by ongoing restructuring efforts, particularly within the company’s North American segment.  continue…

by Roger Montgomery Posted in Companies, Stocks We Like.

• save this article
• POSTED IN Companies, Stocks We Like

Furniture retailer Nick Scali (ASX:NCK) reported its full-year results, and on most measures, the results were in line with consensus estimates. However, there were some surprises, in which an understanding of the nuances led to a reasonably optimistic conclusion for this A1 quality company.  continue…

by Roger Montgomery Posted in Companies, Stocks We Like.

• save this article
• POSTED IN Companies, Stocks We Like

Leading toll road operator, Transurban (ASX:TCL), has released robust financial results, reflecting steady growth and promising prospects. The company’s operational performance, strategic investments, and upcoming projects, such as the Westgate Tunnel and 495 North, position it for further expansion. Despite challenges like inflation and finance costs, Transurban’s solid performance and growth initiatives will mean it retains its position in The Montgomery Fund’s portfolio.  continue…

by Roger Montgomery Posted in Companies, Stocks We Like.

• save this article
• POSTED IN Companies, Stocks We Like

In the June 2024 quarter, the Polen Capital Global Growth Fund purchased new positions in Zoetis (ASX:ZTS) and Shopify (NYSE:SHOP) and eliminated our position in Autodesk (NASDAQ:ADSK). We also trimmed our positions in Microsoft (NASDAQ:MSFT), ServiceNow (NYSE:NOW), Amazon (NASDAQ:AMZN), and LVMH Moet Hennessy Louis Vuitton SE (EPA:MC) and added to our existing position in MSCI (NYSE:MSCI).  continue…

by Polen Capital Posted in Companies, Polen Capital, Stocks We Like.

• save this article
• POSTED IN Companies, Polen Capital, Stocks We Like

ResMed (ASX:RMD) reported its June quarter and full year results after the U.S. market closed on Friday morning. The company met consensus expectations for both revenue and earnings.   

ResMed’s revenue rose nine per cent to US$1.2 billion ($1.85 billion) in the last quarter of fiscal 2024, taking quarterly dividends to US$0.53 per share, up 10 per cent. Operating profit was up 38 per cent, and non-GAAP operating profit was up 30 per cent.  continue…

by Roger Montgomery Posted in Companies, Editor's Pick, Stocks We Like.

• save this article
• POSTED IN Companies, Editor's Pick, Stocks We Like

Today Rio Tinto (ASX:RIO) delivered its first half calendar year 2024 results (1HCY24). The results were largely in line, with an underlying net profit after tax (NPAT) of US$5.75 billion within one per cent of consensus estimates and driven predominantly by Rio Tinto’s copper and aluminium divisions. Both net debt and free cash flow were also in line with expectations.  continue…

by Roger Montgomery Posted in Companies, Stocks We Like.

• save this article
• POSTED IN Companies, Stocks We Like

The Australian Eagle Asset Management investment team has had a long history with Treasury Wine Estates (ASX:TWE). The most recent holding was for several years prior to the pandemic with positive performance supported by growing profit and margins generated by the success of Penfolds in China. This time around, we see another opportunity for medium-term change thesis that may drive a material re-rating of the share price. continue…

by Alan Kwan Posted in Companies, Editor's Pick, Stocks We Like.

• save this article
• POSTED IN Companies, Editor's Pick, Stocks We Like

I had the pleasure of joining Chris Batchelor to present a webinar hosted by Stockopedia as part of their Investing Mastermind series. We delved into unlocking the secrets of stock selection and identifying high-quality stocks. continue…

by Roger Montgomery Posted in Editor's Pick, Stocks We Like, Talks.

• save this article
• POSTED IN Editor's Pick, Stocks We Like, Talks

In this week’s video insight, I discuss the remarkable progress of Telix Pharmaceuticals (ASX:TLX). Over the past ten months, Telix’s share price has seen significant growth, driven by advancements in radiation imaging and therapy technologies. Their flagship product, Illuccix, is gaining traction in the market. With impressive revenue growth and strategic acquisitions, Telix Pharmaceuticals is well-positioned for continued success in the healthcare sector.  continue…

by David Buckland Posted in Companies, Editor's Pick, Stocks We Like, Video Insights.

• save this article
• POSTED IN Companies, Editor's Pick, Stocks We Like, Video Insights

The Australian superannuation system is often seen as one of the envies of the world. With assets totalling $3.7 trillion, our system is the fourth largest in the world and grew by 10 per cent over 2023 from a combination of contributions made to superannuation and underlying investment performance.   continue…

by Michael Gollagher Posted in Companies, Editor's Pick, Stocks We Like.

• save this article
• POSTED IN Companies, Editor's Pick, Stocks We Like